- Home
- LE vs PRME Comparison
LE vs PRME Comparison
Compare LE & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LE | PRME |
|---|---|---|
| Founded | 1963 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 496.1M | 666.1M |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | LE | PRME |
|---|---|---|
| Price | $15.33 | $3.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $32.50 | $6.42 |
| AVG Volume (30 Days) | 184.0K | ★ 2.5M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.89 | 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,154,442,000.00 | $4,632,000.00 |
| Revenue This Year | $1.55 | $15.20 |
| Revenue Next Year | $2.38 | $316.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $7.65 | $1.11 |
| 52 Week High | $20.04 | $6.94 |
Technical Indicators
Market Signals| Indicator | LE | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 40.51 | 47.69 |
| Support Level | $13.72 | $3.73 |
| Resistance Level | $16.57 | $4.66 |
| Average True Range (ATR) | 0.93 | 0.30 |
| MACD | -0.21 | 0.01 |
| Stochastic Oscillator | 2.51 | 39.73 |
Price Performance
Historical ComparisonAbout LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.